FOXC1 and cancer: This pattern was also observed in patients with TNBCs compared with those with HR-positive cancers (FOXC1: FC = 3.17; 95% CI, 2.86 to 3.50; P < .001; FOXA1: FC = −4.73; 95% CI, −5.30 to −4.16; P < .001) (eFigure 6A-D in Supplement 1).